Figure 2

Figure 2

Average MDS-UPDRS scores from baseline (Day 0) to Day 360 (12 months) in participants with evaluable MDS-UPDRS scores from baseline to 12 months, and grouped according to high and low CSF GluSph levels at baseline

Format

PNG

Source

Gain Therapeutics, Inc.

Downloads